Other search tools

About this data

The publication data currently available has been vetted by Vanderbilt faculty, staff, administrators and trainees. The data itself is retrieved directly from NCBI's PubMed and is automatically updated on a weekly basis to ensure accuracy and completeness.

If you have any questions or comments, please contact us.

Results: 1 to 10 of 29

Publication Record

Connections

Bcl2-Expressing Quiescent Type B Neural Stem Cells in the Ventricular-Subventricular Zone Are Resistant to Concurrent Temozolomide/X-Irradiation.
Cameron BD, Traver G, Roland JT, Brockman AA, Dean D, Johnson L, Boyd K, Ihrie RA, Freeman ML
(2019) Stem Cells 37: 1629-1639
MeSH Terms: Animals, Antineoplastic Agents, Alkylating, Apoptosis, Chemoradiotherapy, DNA Breaks, Double-Stranded, DNA Repair, Disease Models, Animal, Drug Resistance, Female, Glioblastoma, Lateral Ventricles, Male, Mice, Mice, Inbred C57BL, Neural Stem Cells, Neurogenesis, Proto-Oncogene Proteins c-bcl-2, Temozolomide, X-Ray Therapy
Added March 3, 2020
0 Communities
2 Members
0 Resources
19 MeSH Terms
Rabbit Model of Intra-Arterial Chemotherapy Toxicity Demonstrates Retinopathy and Vasculopathy Related to Drug and Dose, Not Procedure or Approach.
Daniels AB, Froehler MT, Nunnally AH, Pierce JM, Bozic I, Stone CA, Santapuram PR, Tao YK, Boyd KL, Himmel LE, Chen SC, Du L, Friedman DL, Richmond A
(2019) Invest Ophthalmol Vis Sci 60: 954-964
MeSH Terms: Animals, Antineoplastic Agents, Antineoplastic Agents, Alkylating, Carboplatin, Dose-Response Relationship, Drug, Electroretinography, Female, Fluorescein Angiography, Humans, Infant, Infusions, Intra-Arterial, Male, Melphalan, Models, Animal, Ophthalmic Artery, Rabbits, Retina, Retinal Diseases, Retinal Neoplasms, Retinal Vessels, Retinoblastoma, Retrospective Studies, Tomography, Optical Coherence
Added July 29, 2019
0 Communities
2 Members
0 Resources
23 MeSH Terms
Pharmacokinetics, Tissue Localization, Toxicity, and Treatment Efficacy in the First Small Animal (Rabbit) Model of Intra-Arterial Chemotherapy for Retinoblastoma.
Daniels AB, Froehler MT, Pierce JM, Nunnally AH, Calcutt MW, Bridges TM, LaNeve DC, Williams PE, Boyd KL, Reyzer ML, Lindsley CW, Friedman DL, Richmond A
(2018) Invest Ophthalmol Vis Sci 59: 446-454
MeSH Terms: Animals, Antineoplastic Agents, Alkylating, Disease Models, Animal, Electroretinography, Fluorescein Angiography, Infusions, Intra-Arterial, Melphalan, Ophthalmic Artery, Rabbits, Retina, Retinal Neoplasms, Retinoblastoma, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Tissue Distribution, Treatment Outcome, Vitreous Body
Added April 5, 2018
1 Communities
3 Members
0 Resources
16 MeSH Terms
Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: a randomized clinical trial.
Carvajal RD, Sosman JA, Quevedo JF, Milhem MM, Joshua AM, Kudchadkar RR, Linette GP, Gajewski TF, Lutzky J, Lawson DH, Lao CD, Flynn PJ, Albertini MR, Sato T, Lewis K, Doyle A, Ancell K, Panageas KS, Bluth M, Hedvat C, Erinjeri J, Ambrosini G, Marr B, Abramson DH, Dickson MA, Wolchok JD, Chapman PB, Schwartz GK
(2014) JAMA 311: 2397-405
MeSH Terms: Adult, Aged, Aged, 80 and over, Antineoplastic Agents, Alkylating, Benzimidazoles, Dacarbazine, Disease Progression, Female, Humans, Male, Melanoma, Middle Aged, Survival Analysis, Temozolomide, Treatment Outcome, Uveal Neoplasms
Added June 27, 2014
0 Communities
1 Members
0 Resources
16 MeSH Terms
Phase II study of bendamustine in relapsed chemotherapy sensitive or resistant small-cell lung cancer.
Lammers PE, Shyr Y, Li CI, Hutchison AS, Sandler A, Carbone DP, Johnson DH, Keedy VL, Horn L
(2014) J Thorac Oncol 9: 559-62
MeSH Terms: Adult, Aged, Antineoplastic Agents, Alkylating, Bendamustine Hydrochloride, Drug Resistance, Neoplasm, Female, Follow-Up Studies, Humans, Lung Neoplasms, Male, Middle Aged, Neoplasm Recurrence, Local, Neoplasm Staging, Nitrogen Mustard Compounds, Prognosis, Salvage Therapy, Small Cell Lung Carcinoma, Survival Rate
Added April 23, 2014
0 Communities
1 Members
0 Resources
18 MeSH Terms
Integrating cell-based and clinical genome-wide studies to identify genetic variants contributing to treatment failure in neuroblastoma patients.
Pinto N, Gamazon ER, Antao N, Myers J, Stark AL, Konkashbaev A, Im HK, Diskin SJ, London WB, Ludeman SM, Maris JM, Cox NJ, Cohn SL, Dolan ME
(2014) Clin Pharmacol Ther 95: 644-52
MeSH Terms: Antineoplastic Agents, Alkylating, Brain Neoplasms, Cell Line, Tumor, Child, Cohort Studies, Cyclohexylamines, Cyclophosphamide, Disease-Free Survival, Drug Resistance, Neoplasm, Genetic Predisposition to Disease, Genetic Variation, Genome-Wide Association Study, Humans, Neuroblastoma, Phenotype, Polymorphism, Single Nucleotide, Quality Control, RNA, Small Interfering, Real-Time Polymerase Chain Reaction, Risk Assessment, Treatment Failure
Added February 22, 2016
0 Communities
2 Members
0 Resources
21 MeSH Terms
Cyclophosphamide creates a receptive microenvironment for prostate cancer skeletal metastasis.
Park SI, Liao J, Berry JE, Li X, Koh AJ, Michalski ME, Eber MR, Soki FN, Sadler D, Sud S, Tisdelle S, Daignault SD, Nemeth JA, Snyder LA, Wronski TJ, Pienta KJ, McCauley LK
(2012) Cancer Res 72: 2522-32
MeSH Terms: Animals, Antineoplastic Agents, Alkylating, Bone Marrow, Bone Neoplasms, Cell Line, Tumor, Chemokine CCL2, Cyclophosphamide, Docetaxel, Humans, Interleukin-6, Male, Mice, Myeloid Cells, Neoplasm Transplantation, Prostatic Neoplasms, Taxoids
Added March 5, 2014
0 Communities
1 Members
0 Resources
16 MeSH Terms
Phase II, open-label, randomized trial of the MEK1/2 inhibitor selumetinib as monotherapy versus temozolomide in patients with advanced melanoma.
Kirkwood JM, Bastholt L, Robert C, Sosman J, Larkin J, Hersey P, Middleton M, Cantarini M, Zazulina V, Kemsley K, Dummer R
(2012) Clin Cancer Res 18: 555-67
MeSH Terms: Adult, Aged, Aged, 80 and over, Antineoplastic Agents, Alkylating, Benzimidazoles, DNA Mutational Analysis, Dacarbazine, Disease-Free Survival, Drug Substitution, Female, Humans, Kaplan-Meier Estimate, MAP Kinase Kinase 1, MAP Kinase Kinase 2, Male, Melanoma, Middle Aged, Mutation, Neoplasm Staging, Proto-Oncogene Proteins B-raf, Proto-Oncogene Proteins p21(ras), Temozolomide, Treatment Outcome, Young Adult
Added March 20, 2014
0 Communities
1 Members
0 Resources
24 MeSH Terms
Ecteinascidin 743 interferes with the activity of EWS-FLI1 in Ewing sarcoma cells.
Grohar PJ, Griffin LB, Yeung C, Chen QR, Pommier Y, Khanna C, Khan J, Helman LJ
(2011) Neoplasia 13: 145-53
MeSH Terms: Antineoplastic Agents, Alkylating, Bone Neoplasms, Cell Line, Tumor, Child, DAX-1 Orphan Nuclear Receptor, Dioxoles, Europe, Gene Expression Regulation, Neoplastic, Humans, Oncogene Proteins, Fusion, Promoter Regions, Genetic, Proto-Oncogene Protein c-fli-1, RNA-Binding Protein EWS, RNA-Binding Protein FUS, Sarcoma, Sarcoma, Ewing, Tetrahydroisoquinolines, Trabectedin, Transcription Factor CHOP
Added September 3, 2013
0 Communities
2 Members
0 Resources
19 MeSH Terms
Earlier detection of tumor treatment response using magnetic resonance diffusion imaging with oscillating gradients.
Colvin DC, Loveless ME, Does MD, Yue Z, Yankeelov TE, Gore JC
(2011) Magn Reson Imaging 29: 315-23
MeSH Terms: Animals, Antineoplastic Agents, Alkylating, Brain Neoplasms, Carmustine, Cell Line, Tumor, Diffusion Magnetic Resonance Imaging, Early Diagnosis, Glioma, Male, Oscillometry, Prognosis, Rats, Rats, Inbred F344, Treatment Outcome
Added November 13, 2013
0 Communities
3 Members
0 Resources
14 MeSH Terms